Replies to post #3457 on RespireRx Pharmaceuticals Inc (fka RSPI)

[Aiming4]

The current price doesn't assume CX717 is going to be usable for anything.

If I could get a good feeling that is true, I'd buy even more right now.

But if CX-717 gets shot down by the FDA in a few months, or it becomes obvious that Cortex would have to spend a lot more time and resources trying to get the FDA to liberalize CX-717's dosing limits, I think the stock price will take a significant hit. As a WAG, say a drop to .80

The reason (in spite of the above) that I added some COR last week was because if the FDA does kill CX-717 for ADHD, it likely forces Cortex into a licensing agreement that would be less than Cortex had hoped for, but which gets Ampakines under a BPs umbrella for development.

And that likely would have a favorable effect on the stock price.

So buying shares now yields a huge reward if the FDA gives a good decision on CX-717, but has limited downside if it forces Cortex into a BP deal since that should cause the pps to recover to at least its current level... Aiming4.

[jerrydylan]

The most bullish thing COR can do now is go up, volume would help. There is a downtrend line from from a rally failure 10-10-06 @ $3.40 right thru 10-26-06 @ $3.15 right thru the secondary news 1-16-07 @ $1.34 that line goes thru $1.10 right about now and I think breaking thru that line takes us quickly to $1.25-1.35 where a little basing would be a good thing. This would begin a reverse head and shoulders, which I think could lead to a much bigger formation with right and left shoulder up around $3 head at $1.25
http://stockcharts.com/education/ChartAnalysis/headShouldersBottom.html

[gfp927z]

Neuro, I guess I'm just tired of this damn stock. I have no desire to roll the dice here as a long, but it would be interesting to see what the heck is actually going on with this histo phenomenon. Even if CX-717 gets abandoned, I wonder if Stoll & Co will reveal the full details even then?
If not, I don't know why I bother sticking around, other than the lack of anything better to do. I would like to see if the high impact approach pans out, but that will be a number of years.

All I know is I sure wouldn't bet the farm on this thing, but that gets back to that verboten word (diversification). Just wondering Neuro, hypothetically, if you had never owned Cortex previously, and had no ongoing emotional stake in it, would you take such a large position at this juncture as you have (assuming you understood the full potential of the technology as you do, just without the ongoing emotional attachment)? Just curious, since I find the psychological aspects of investing fascinating. I always tried to invest unemotionally like Spock, but always wound up more like Woody Allen, hence my current preoccupation with hyper-conservative strategies :o)